Background Group B streptococcal disease is one of the most common infections in the first
week after birth. In 2002, national guidelines recommended universal late antenatal …

Background Guidelines issued in 1996 in the United States recommend either screening of
pregnant women for group B streptococcal colonization by means of cultures (screening …

Background Group B streptococcal infections are a leading cause of neonatal mortality, and
they also affect pregnant women and the elderly. Many cases of the disease in newborns …

Universal screening for group B streptococcus (GBS) among women at 35 to37 weeks of
gestation is more effective than administration of intrapartumantibiotics based on risk factors …

During the 1990s, the incidence of disease caused by mother-to-child transmission of group
B streptococcus fell by 65 percent, from 1.7 to 0.6 case per 1000 live births. 1 The decline …

Group B streptococcus (GBS) is a leading cause of neonatal morbidity and mortality in the
United States. In 2002, CDC, the American College of Obstetricians and Gynecologists …

Objective: To evaluate the potential impact of ACOG and Centers for Disease Control and
Prevention (CDC) consensus strategies for the prevention of perinatal group B streptococcal …

OBJECTIVE: To estimate the effectiveness against early-onset group B streptococcal (GBS)
disease of intrapartum antibiotic prophylaxis among term and preterm deliveries, deliveries …

Objective: To assess the feasibility and efficacy of a protocol for universal screening for
group B streptococci combined with selective intrapartum prophylaxis at a teaching hospital …

Background Group B streptococcal infections are an important cause of neonatal morbidity
and mortality. A rapid method for the detection of this organism in pregnant women at the …